The U.S. Patent and Trademark Office has resisted researchers' overreaching in their patenting of genes, and researchers' work is seldom compromised by patents.

Policymakers at both ends of Pennsylvania Avenue want to get the American economy growing again. Growth can lower unemployment, and it can yield the revenues needed to fill federal coffers. The key to robust economic growth is innovation. So how do we get it?

Lawmakers need to take a closer look at how to treat fraud at the Patent and Trademark Office.

The prophets of American decline are on the march in numbers not seen since the days of Jimmy Carter and stagflation. Who knows, maybe this time they'll be right--a sclerotic political system, enterprise-stifling regulations, a foolish tax structure and shortsighted public policy may finally send the U.S. economy into the permanent tailspin long predicted by experts with a grim turn of mind.

The patenting of gene-related inventions--specifically, the discovery and application of gene sequences for medical and other purposes--is a topic that is both extremely important and little understood beyond a narrow circle of lawyers and research organizations. These patents apply to knowledge that is of great public and private value in...

In patent politics there is more at stake than money.

The U.S. Patent Lawis now showing its age and is in need of reform.

Government should address intellectual property reform carefully and with caution.